A Study of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Vincent Picozzi, MD
Virginia Mason Medical Center - Benaroya Research Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Honorhealth Research Institute
Scottsdale, Arizona, United States
- University of California, Los Angeles
Los Angeles, California, United States
- Georgetown University - Medstar Health Research Institute
Washington D.C., District of Columbia, United States
- Mayo Clinic Florida
Jacksonville, Florida, United States
- Ochsner Clinic Foundation
New Orleans, Louisiana, United States
- Virginia Piper Cancer Institute
Minneapolis, Minnesota, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- Virginia Mason Medical Center - Benaroya Research Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2014
- Primary completion
- 15 Dec 2021
- Completion
- 15 Dec 2021
- Last update posted
- 2 Mar 2023
- Registered enrollment
- 37
- Registry id
- NCT02210559
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.